Literature DB >> 11733376

Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells.

Y Yu1, J Varughese, L F Brown, J B Mulliken, J Bischoff.   

Abstract

Infantile hemangiomas are endothelial tumors that grow rapidly in the first year of life and regress slowly during early childhood. Although hemangiomas are well-known vascular lesions, little is known about the mechanisms that cause the excessive endothelial cell proliferation in these most common tumors of infancy. To investigate the molecular basis of hemangioma, we isolated endothelial cells from several proliferative-phase lesions and showed that these cells are clonal and exhibit abnormal properties in vitro (E. Boye, Y. Yu, G. Paranya, J. B. Mulliken, B. R. Olsen, J. Bischoff: Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001, 107:745-752). Here, we analyzed mRNA expression patterns of genes required for angiogenesis, including members of the vascular endothelial growth factor (VEGF)/VEGF receptor family and the angiopoietin/Tie family, in hemangioma-derived and normal endothelial cells. KDR, Flt-1, Tie1, Tie2, and angiopoietin-2 (Ang2) were strongly expressed in cultured hemangioma-derived endothelial cells and in hemangioma tissue. In contrast, there was little expression of angiopoietin-1 (Ang1) or VEGF. We found Tie2 mRNA and protein up-regulated with a concomitant increase in cellular responsiveness to Ang1 in most hemangioma-derived endothelial cells. Ang2 mRNA was down-regulated in response to serum in hemangioma-derived endothelial cells, but not in normal endothelial cells, suggesting altered regulation. These findings implicate Tie2 and its ligands Ang1 and Ang2 in the pathogenesis of hemangioma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733376      PMCID: PMC1850579          DOI: 10.1016/S0002-9440(10)63077-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Cutaneous vascular anomalies.

Authors:  J B Mulliken
Journal:  Semin Vasc Surg       Date:  1993-12       Impact factor: 1.000

Review 2.  Tek/Tie2 signaling: new and old partners.

Authors:  N Jones; D J Dumont
Journal:  Cancer Metastasis Rev       Date:  2000       Impact factor: 9.264

3.  Clonality and altered behavior of endothelial cells from hemangiomas.

Authors:  E Boye; Y Yu; G Paranya; J B Mulliken; B R Olsen; J Bischoff
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

4.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

5.  Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements.

Authors:  B R Smoller; D B Apfelberg
Journal:  J Cutan Pathol       Date:  1993-08       Impact factor: 1.587

6.  Vascular permeability factor mRNA and protein expression in human kidney.

Authors:  L F Brown; B Berse; K Tognazzi; E J Manseau; L Van de Water; D R Senger; H F Dvorak; S Rosen
Journal:  Kidney Int       Date:  1992-12       Impact factor: 10.612

7.  Cellular markers that distinguish the phases of hemangioma during infancy and childhood.

Authors:  K Takahashi; J B Mulliken; H P Kozakewich; R A Rogers; J Folkman; R A Ezekowitz
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

9.  Expression of VE (vascular endothelial)-cadherin and other endothelial-specific markers in haemangiomas.

Authors:  I Martìn-Padura; C De Castellarnau; S Uccini; E Pilozzi; P G Natali; M R Nicotra; F Ughi; C Azzolini; E Dejana; L Ruco
Journal:  J Pathol       Date:  1995-01       Impact factor: 7.996

10.  Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.

Authors:  C Ffrench-Constant; L Van de Water; H F Dvorak; R O Hynes
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  39 in total

Review 1.  Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.

Authors:  Shoshana Greenberger; Joyce Bischoff
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

Review 2.  Application of angiogenesis to clinical dermatology.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Adv Dermatol       Date:  2008

3.  A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.

Authors:  Kathleen N Moore; Michael W Sill; Meaghan E Tenney; Christopher J Darus; David Griffin; Theresa L Werner; Peter G Rose; Robert Behrens
Journal:  Gynecol Oncol       Date:  2015-07-11       Impact factor: 5.482

4.  CIZ1 Expression Is Upregulated in Hemangioma of the Tongue.

Authors:  Yue Wang; Xiaorui Li; Jiahao Zhang; Qiang Liu; Peng Gao; Di Li; Shijie Zhang; Ju Liu
Journal:  Pathol Oncol Res       Date:  2018-11-19       Impact factor: 3.201

5.  Gingipains from the Periodontal Pathogen Porphyromonas gingivalis Play a Significant Role in Regulation of Angiopoietin 1 and Angiopoietin 2 in Human Aortic Smooth Muscle Cells.

Authors:  Boxi Zhang; Hazem Khalaf; Allan Sirsjö; Torbjörn Bengtsson
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

6.  Microarray analysis of port wine stains before and after pulsed dye laser treatment.

Authors:  Vivian T Laquer; Peter A Hevezi; Huguette Albrecht; Tina S Chen; Albert Zlotnik; Kristen M Kelly
Journal:  Lasers Surg Med       Date:  2013-02       Impact factor: 4.025

7.  Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis.

Authors:  Luni Emdad; Seok-Geun Lee; Zhao Zhong Su; Hyun Yong Jeon; Habib Boukerche; Devanand Sarkar; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-25       Impact factor: 11.205

8.  Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice.

Authors:  Sulochana S Bhandarkar; Marisa Jaconi; Levi E Fried; Michael Y Bonner; Benjamin Lefkove; Baskaran Govindarajan; Betsy N Perry; Ravi Parhar; Jamie Mackelfresh; Allie Sohn; Michael Stouffs; Ulla Knaus; George Yancopoulos; Yvonne Reiss; Andrew V Benest; Hellmut G Augustin; Jack L Arbiser
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

9.  Human pulmonary valve endothelial cells express functional adhesion molecules for leukocytes.

Authors:  Evan L Dvorin; Joel Jacobson; Stephen J Roth; Joyce Bischoff
Journal:  J Heart Valve Dis       Date:  2003-09

10.  Analysis of circulating hem-endothelial marker RNA levels in preterm infants.

Authors:  Tzipora Strauss; Sally Metsuyanim; Itai Pessach; Irit Shuchan-Eisen; Jacob Kuint; Benjamin Dekel
Journal:  BMC Pediatr       Date:  2009-06-25       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.